NIH to Address Dwindling Clinical Trial Patient Enrollment With Centralized Staffing Support


A new initiative by the National Cancer Institute (NCI), part of the National Institutes of
Health, aims to tackle the steep decline in participation in NCI-funded cancer clinical trials that
is due in part to clinical trials staffing shortages that were exacerbated by the COVID-19
pandemic. These shortfalls have hampered clinical trials activities across the country,
particularly in rural and underserved areas.

© 2021 FLASCO | Premium Website Design by The HDG